Drug intelligence / Profile preview

ChAdOx1 NipahB

Development stage
Phase 2
Lead developer
University of Oxford
Modality
Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
Administration
Intramuscular
01

Overview

ChAdOx1 NipahB is a viral vector vaccine candidate developed by the University of Oxford in collaboration with the Serum Institute of India (SII) to prevent Nipah virus infection. The vaccine utilizes the ChAdOx1 platform, a replication-deficient chimpanzee adenoviral vector, to deliver the genetic sequence of the Nipah virus glycoprotein (G). This glycoprotein is a critical component for viral entry and a primary target for the host's neutralizing antibody response. Funded by the Coalition for Epidemic Preparedness Innovations (CEPI), the vaccine is designed to provide protection against a highly lethal zoonotic pathogen for which no approved vaccines currently exist. It is currently in Phase 2 clinical development.

Other names
Nipah virus vaccine (ChAdOx1)
02

Targets

NiV-G (Nipah virus attachment glycoprotein)

Beyond the preview

Go deeper on ChAdOx1 NipahB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChAdOx1 NipahB.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call